Abstract
Tumors associated with infection by human papillomavirus are a public health problem in developing countries. Despite the prophylactic vaccine commercially available, the study of mechanisms trigger tolerance by the tumor are very important for new immunotherapies. Our laboratory has been using a tumor model associated with HPV16, strain TC-1 injected subcutaneously in mice, which allowed…